Van Moorsel Endocrinologie SRL
Van Moorsel Endocrinologie reported total assets of 288,095 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Van Moorsel Endocrinologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +210 % Total assets +102 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Van Moorsel Endocrinologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
Van Moorsel Endocrinologie's financial analysis
- Solvency86.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Van Moorsel Endocrinologie
Van Moorsel Endocrinologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0797.761.553
- VAT number
- BE0797761553
- Peppol
- Registered · 0208:0797761553 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jan 2023
- Registered office
- 3680 Maaseik
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Van Moorsel Endocrinologie (SRL) has been based in Maaseik since 2023, active in: medical specialists activities. For 2025, it reports a net profit of 168,719 € and equity of 249,963 €; its revenue is not published. Its solvency stands at 86.8%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Van Moorsel Endocrinologie
Companies in the same business, of comparable size and area, outside its group.
- Dokter Dieter Podevyn - Algemene Geneeskunde Medical specialists activities Asse · balance sheet 290,503 €
- DR. Jense WILS Medical specialists activities Brecht · balance sheet 287,941 €
- Dr. Biesemans Linda, anesthesie Medical specialists activities Deinze · balance sheet 288,448 €
- Dr. Inne Renders, Medische Oncologie Medical specialists activities Kasterlee · balance sheet 288,472 €
- Docteur Rotea Cristina Medical specialists activities Anderlecht · balance sheet 287,572 €
- Dr. Pia Stevens Chirurg Medical specialists activities Hasselt · balance sheet 287,507 €
- Somnus Médical Medical specialists activities Mont-Saint-Guibert · balance sheet 287,461 €
- Dr. Irma de Bruin Medical specialists activities Pelt · balance sheet 286,916 €
Frequently asked questions about Van Moorsel Endocrinologie
What is the revenue of Van Moorsel Endocrinologie?
Van Moorsel Endocrinologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Van Moorsel Endocrinologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0797761553 for Van Moorsel Endocrinologie, if the company is VAT-registered. Its company number (CBE) is 0797.761.553.
Where is the registered office of Van Moorsel Endocrinologie?
According to the CBE register, the registered office of Van Moorsel Endocrinologie is in 3680 Maaseik.
What is the equity of Van Moorsel Endocrinologie?
At the close of the 2025 financial year, the equity of Van Moorsel Endocrinologie amounts to 249,963 €, a solvency of 86.8% of total assets.
Who manages Van Moorsel Endocrinologie?
The register lists 1 active mandates at Van Moorsel Endocrinologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Van Moorsel Endocrinologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →